The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition
$8,250.00 – $16,500.00
The most essential report on the IVD industry, this 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry for two decades.
In its latest report Kalorama Information estimates the market for in vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars. This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVD-19 testing responsible for most of the growth. Other infectious diseases (particularly respiratory pathogens), advanced cancer IVDs and increasing used of critical care and hematology tests are among the factors for additional growth.
Kalorama Information’s estimates stand out from others because the firm is a focused publisher of in vitro diagnostics market research and not an entity publishing reports on all topics. Months of analysis ad review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal lite
rature result in reliable global market modeling, trusted by many of the top companies in the market.
Never before has in vitro diagnostics been so crucial. Tests for cancer and infectious disease detection, transplant success, pharmaceutical selection have added healthcare value and improved outcomes. Genetic tests for rare diseases and prenatal assessment are increasingly utilized. And now, the COVID-19 pandemic has highlighted how important testing is in a way that could not be imagined.
But in vitro diagnostics represents a large market, with scores of significant competitors. Sorting out the marketplace can be difficult without a definitive guide. What is the market size for clinical chemistry, immunoassays, molecular tests, hematology tests and other test categories?
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. For two decades, the 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry.
Comprehensive Market Coverage
As part of its offering, this report includes:
COVID-19 Impact on Markets, and COVID-19 Test Markets
1500 + Page Report Based on Vendor Reporting, Interviews, Vendor Activities
Authored by Veteran IVD Analysts with Industry Knowledge
12 Detailed Market Chapters with 2020 Market Estimates
Where is IVD Heading? – Market Segment Projections to 2025
Regional Breakouts Including Country IVD Markets
Sections on China and The United States IVD Markets
Coverage of Growth Markets: Eastern Europe and the Middle East, and Southeast Asia
Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
Industry-Standard Business Planning Tools
Coverage of Trends and Market Estimates for Essential IVD Segments
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2025 for defined segments of the IVD market and various sub-segments, including:
Point-of-Care Testing (POC) (Professional and Self-Testing)
Glucose Testing
Substance Abuse Testing
Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2025 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers’ product innovations. The market data is put into a context with real-world industry and medical practice trends.
The Worldwide Market for In Vitro Diagnostic Tests has been called “The Bible of the IVD Industry” by customers, which include top IVD firms. Using Kalorama Information’s The Worldwide Market for In vitro Diagnostic (IVD) Tests, 13th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.
Country-Level Coverage
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
US
Germany
UK
France
Spain
Italy
Russia
Netherlands
Turkey
Poland
Canada
China
Japan
Malaysia
Singapore
South Korea
Australia
Saudi Arabia
Brazil
Argentina
Colombia
Chile
Peru
South Africa
Eastern Europe
Emerging Markets
Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2020.
IVD Market Infographic
(click to view larger)
Competitive Analysis and Corporate Profiling
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report. Companies profiled include:
A. Menarini Diagnostics
Abbott Diagnostics
Arkray
Becton, Dickinson (BD)
Beckman Coulter
bioMerieux
Bio-Rad
Bruker
Cepheid
Danaher
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Hologic
Illumina
Instrumentation Laboratory
Lab Corp.
Leica Biosystems
Nova Biomedical
Meridian Bioscience, Inc.
Mindray
Perkin Elmer
Qiagen
Quest
Quidel
Radiometer
Randox
Roche Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher Scientific
Werfen
Table of Contents
One: Executive Summary
Figure 1-1: The Worldwide IVD Market, 2020-2025 ($millions)
Scope and Methodology
Table 1-1: Exchange Rate Fluctuations, 2016-2019
Finding What You Are Looking For in the 13th Edition
Table 1-2: Finding What You Are Looking For in the 13th Edition
Size and Growth of the Market
Table 1-3: Global In Vitro Diagnostic Sales by Product Market, 2020-2025 ($ millions)
IVD Market Highlights
Competitive Picture in IVD
What to Watch
Next-Generation Sequencing and IVD
Direct-to-Consumer
Gene Editing
Liquid Biopsy
Information Technology and AI
New Venues – Urgent & Retail Care
Two: Introduction
IVD Landscape
Market Analysis of IVD Market Segments
Table 2-1: Global In Vitro Diagnostic Sales by Product Market, 2020-2025 ($ million) (COVID-19 Molecular, COVID-19 Immunoassay, Clinical Chemistry; Immunoassays, Infectious Disease; Immunoassays, Other; Blood Bank Screening; Drugs of Abuse; HbA1c Immunoassays, Lab-Based; Hematology; Microbiology (ID/AST); Molecular Microbiology; Radioimmunoassays; Coagulation; Histology/Cytology; HPV, molecular; Nucleic Acid Assays; Blood Grouping/Typing; Blood Bank Molecular; Circulating Tumor Cells; POC, OTC diabetes; Continuous Glucose; POC, OTC Other; POC Professional; Mass Spectrometry)
Top Suppliers and Niche Players
Introduction
Overview of the Top Tier Companies
Table 2-2: Revenues of Selected Top IVD Companies, 2015-2019 ($ million, estimated)
Figure 2-1: Share of IVD Market by Segment, Percentage, 2000 and 2020 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays,
Microbiology (ID/AST), POC Diabetes, POC – Other, Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
Future
Point of View
Three: The Global Picture for In Vitro Diagnostic Markets
Background
Simultaneous Threats: Chronic and Acute
Expected World IVD Market Developments
The Aging Planet
Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
Workforce Reduction
Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World))
Is the World Prepared for Aging?
Shifting Disease Burdens
Increase in Chronic Diseases
Emerging and Emerged Markets
Table 3-4: Available Market Data, 2018 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Columbia, Ukraine, Egypt, Malaysia))
Emerging Nations and Health Insurance
Size and Forecast for the Global IVD Market
Table 3-5: Global In Vitro Diagnostic Market (including non-traditional IVD revenues); Major Country/Region Markets, 2019 and 2024 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, Eastern Europe, Brazil, India, Russia, Australia, Turkey, Mexico, Saudi Arabia, South Korea)
Table 3-12: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
Clinical Laboratory Tests in China
Figure 3-9: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015 (General Hospitals, Specialized Hospitals, Chinese Medical Hospitals, Community Health Service Centers, Health Centers [Urban and Township], Village Clinics, Others)
Private Laboratories
Distribution in China
India: Home to Every Sixth Person in the World
Table 3-14: Asia Pacific IVD Market by Country, 2019 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
Brazil: LATAM Leader
Disease Trends
Table 3-15: Brazil IVD Market by Segment, 2019 (%)
The Russian Federation
Canada
Emerging Markets
Saudi Arabia IVD Market
South Africa IVD Market
Turkey IVD Market
Columbia IVD Market
United Arab Emirates (UAE) IVD Market
South Korea IVD Market
Other Markets to Watch
IVD Market Opportunity
Table 3-17: IVD Market Opportunity by Country (2019 Market Rank, 2018 Market Rank, Country CAGR 2020-2025) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)
Four: Company and Industry Trends
Introduction
Advanced Medicine Without Borders
China Market Information
IVD Company Initiatives in China
Table 4-1: Selected IVD Initiatives in China
Clinical Genetic Test Advances
Direct to Consumer Genetic Test Services
Programs and Initiatives
Table 4-6: Selected AI Product Initiatives in Development and Collaborations
IBM Watson Health
AI in Liquid Biopsy
Table 4-7: Selected AI/Liquid Biopsy Initiatives
Future Trends
Exosome Sequencing
Table 4-8: Selected Exosome Test Innovations
Biotin Interference in Immunoassay Detection Errors
Table 4-9: Biotin-free Offerings Currently on the Market
Traumatic Brain Injury and IVD
Blockchain
Substance Abuse
Early Sepsis Detection
Five: Point-of-Care Tests
Overview and Trends
Professional POC
Table 5-1 Professional POC Test Sales by Category, Worldwide 2019 -2024 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
Table 5-2: Selected Profession POC Test Innovations
OTC Self Testing
Table 5-3: POC Self-Test Sales by Category, Worldwide, 2020-2025 ($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc])
Pregnancy/Fertility Tests
Table 5-4: POC Pregnancy and Fertility Test Market Distribution by End User, 2019 (%) (OTC, PRO)
Table 5-5: Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
Colon Cancer Screening
Table 5-6: Colon Cancer POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
Lipid Testing
Table 5-7: Lipid POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
POC Infectious Disease Testing
Table 5-8: Innovations in Molecular POC Infectious Disease Diagnostics
Products
HIV and Hepatitis Testing and Monitoring
Tuberculosis
Tropical and Neglected Diseases
Respiratory Diseases
Sepsis and Nosocomial Disease
Sexual Health
Lyme Disease
Table 5-9: Innovations in Molecular POC Infectious Disease Diagnostics
Market Size and Growth
Table 5-10: Infectious Disease POC Test Demand by Type, 2019 (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
Table 5-11: Infectious Disease POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
Table 7-3: Selected Immunoassay Innovations on Core Lab Instruments
Radioimmunoassays
Market Analysis
Leading Suppliers and Growth Potential
Table 7-4 Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2020-2025 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
Table 7-5: Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
Table 7-6: Selected Immunoassay Quality Control Products
Table 7-7: 2019 Revenue of Leading Immunoassay Vendors (in millions $), Estimated
Mature Assay Segment
Thyroid Function
Therapeutic Drug Monitoring
Anemia
Toxicology/DAU
Allergy
Maturing Immunoassays
Proteins
Growth Immunoassays
Vitamin D
Table 7-13: Selected Inflammatory Bowel Disease Test Innovations
Transplant Management
Table 7-14: Selected Immunoassays for Transplant Medicine
Women’s Health
Table 7-15: Selected Women’s Health Innovations
Alzheimer’s Disease
Table 7-16: Selected Innovations for Alzheimer’s Disease Immunoassays
Sleep Apnea
Miscellaneous
Table 7-17: Selected Immunoassay Innovations
Point-of-Care OTC and Professional Use
Table 7-18: Global POC Immunoassay Sales Distribution by Region, 2020 (United States, Europe, Japan, RoW)
Table 7-19: Global POC Immunoassay Test Sales by Test Category, 2020-2025 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Other, OTC/Self Total; Professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other, Professional Total)
Pregnancy Testing
Cardiovascular Diagnostics
Drugs of Abuse/Therapeutic Drug Monitoring
Innovating POC
Table 7-21: Selected POC Test Innovations
Table 7-22: Selected POC Immunoassay Test Platforms
The Commercial Outlook for Immunoassays
Eight: Molecular Assays
Overview
Table 8-1: Common Next Generation Molecular Test Traits
Sample Preparation and Quality Control
Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
Advanced Molecular Tests and Technologies
Exosome Sequencing
Table 8-3: Selected Exosome Test Innovations
Liquid Biopsy
Table 8-4: Selected Liquid Biopsy Innovations
Metabolomic Profiling
Information Technology for Test Value
Table 8-5: Selected IT Innovations in Molecular Diagnostics
Forensic Studies – An Emerging Opportunity
Table 8-6: Selected Innovations in Forensic DNA Testing
Test Platforms
Table 8-7: Key Molecular Technologies and Major Players
Table 8-8: Selected Molecular Test Platform Innovations
Major Players
Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2016-2019 (in millions $)
Market Analysis
Table 8-10: Global Molecular Test Sales by Type 2020-2025 (in millions $) (Oncology, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
Oncology
Table 8-11: Global Molecular Cancer Test Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Pharmacodiagnostics
Table 8-12: Global Pharmacodiagnostic Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Table 8-13: Selected Molecular Tumor Marker Test Innovations
Inherited Diseases and Thrombophilia SNPs
Psychiatric Disorders
Prenatal and Newborn Testing
The Commercial Outlook for Molecular Tests
Nine: Hematology
Overview of Hematology and Trends
Digital Image Analysis
Table 9-1: CellaVision Market Share Data by Hematology Vendor 2019
Table 10-5: Global Molecular – Thrombophilia SNP Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Table 10-6: Selected Molecular Coagulation Test Innovations
Leading Suppliers: Laboratory Systems
Table 10-7: Top Coagulation Company Revenues, Laboratory-based – 2019 ($ millions)
Decentralized Coagulation Testing – Professional Use
Decentralized Coagulation Testing – OTC
Table 10-8: Selected POC Coagulation Test Innovations
Platelet Testing
Table 10-9: Selected Platelet Activity Test Innovations
Leading Suppliers: POC Systems
Table 10-10: Top Coagulation Company Revenues, POC – 2019 ($ millions)
The Commercial Market for Coagulation Tests
Table 10-11: Major Anticoagulants Uses and Tests
Eleven: Microbiology and Virology
The Burden of Infectious Disease
Table 11-1: The Top Ten Leading Causes of Death
Hidden Costs of Non-Detection: Secondary Effects
Herpes and Alzheimer’s Disease
Ebola and Cancer
HIV and Cancer
H pylori and Cancer
Bacteria and Parkinson’s
Microbial Antibiotic Resistance – The Role of Clinical Tests
Table 11-2: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
Traditional Microbiology and Its Limits
The New Microbiology – Innovations
Liquid Based Microbiology and Automation Innovations
Post-Blood Culture Microbial ID
PCR and Other NAAT-Based Tests for Infectious Diseases
Table 11-3: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
Microbiome-Related Microbiology Tests
Table 11-4: Selected Microbiome-Based Tests
Next Generation Sequencing-Based Microbiology Approaches
Table 11-5: Selected Companies Applying DNA/RNA Sequencing to Microbiology
Tickborne Diseases: Beyond Lyme
Zika
Chagas
Dengue
Ebola
Chikungunya
Next Threats?
Microbiology Firms Acquisitions and Collaborations
Market Analysis
Table 11-7: Global Microbiology Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Market Analysis – Traditional Microbiology ID/AST
Table 11-8: Global Microbiology ID/AST Market, 2020-2025 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
Table 11-9: Global ID/AST Testing Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Traditional ID/AST
Table 11-10: Global ID/AST Testing, Distribution by Systems, 2019 (%) (Panel, Auto)
Blood Culture
Table 11-11: Selected Advanced Techniques in Positive Blood Culture
Chromogenic Media
Rapid Tests Performed on Colonies from Culture Media
Supplies
Market Analysis – Microbiology Immunoassays
Improvements in Microbiology Immunoassays
Table 11-13: Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2019 (in $ millions) (Hepatitis, HIV, STDs, TORCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other)
Table 11-14: Global Clinical Chemistry Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2020 (North America, Europe, Asia Pacific, RoW)
Table 11-16: Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2019 (%) (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
Market Analysis – Molecular Microbiology
Table 11-17: Global Molecular Microbiology Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
Table 11-18: Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2020-2025 (in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
Molecular Respiratory Infection Testing
Table 11-19: Selected Molecular Point of Care Innovations in Microbiology
Molecular Testing for Sexually Transmitted Diseases
Molecular Hepatitis Testing
Molecular HIV Testing
Table 11-20: Innovations in Molecular POC Diagnostics for HIV
Molecular Tests for Hospital-Acquired Infections (HAIs)
Table 11-21: Frequency of the Most Common Nosocomial Infections
Clostridium Difficile
MRSA
Molecular TB Testing
Limitations of Molecular Microbiology Testing
Mass Spectrometry
Table 11-22: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
The Future Outlook for Microbiology
Twelve: Blood Banking Services
Overview
Table 12-1: History of Blood Testing
The Current Status of Global Blood Collection
Table 12-2: Distribution of Blood Units Collected, 2011-2013 (United States, United Kingdom, India, Japan, China, Canada, ROW, World Total)
Global Blood Safety
Table 12-3: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
Table 12-4: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
Zika Virus
Blood and Component Collection
Table 12-5: Blood Component Usage for Selected Conditions
Table 12-6: Red Blood Cell and Platelet Use by Hospital Services (%)
Reevaluating Blood Transfusions
Table 12-7: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
Ventana Medical Systems Inc. / Roche Tissue Diagnostics
Key Comment
Recent Revenue History
Immunohistochemistry – IHC
Cervical Cancer Screening
Companion Diagnostics
Quality Control
DISCOVERY Product Line
Bloodsource (Vitalant)
Cerus Corporation
Haemokinesis Pty Ltd
Immucor
MicroTyping Concepts
Quotient Limited
Reliance Life Sciences
Diagnostica Stago, S.A.S.
Microvisk Technologies
DIAGON Kft. Hungary
AB SCIEX Pte Ltd.
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
ERBA Diagnostics, Inc.
MedTest DX
Microsaic Systems plc
Nova Biomedical
Scienion AG
Sekisui Diagnostics LLC
Shimadzu Scientific Instruments
Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
Tecan Group
Tosoh Bioscience
Trinity Biotech Plc
Angle, plc
Biocartis
Biocept, Inc.
Biodesix
Cynvenio Biosystems (LungLife AI)
Epic Sciences
Epigenomics AG
Foundation Medicine, Inc.
Genomic Health (Exact Sciences)
Guardant Health, Inc.
Menarini-Silicon Biosystems
Myriad Genetics, Inc.
Natera
NeoGenomics
Animas Corporation
Ascensia Diabetes Care Holdings AG
Bigfoot Biomedical Inc.
Cellnovo Group SA
Debiotech SA
Dexcom Inc.
Gentag Inc.
Glooko Inc.
GlySure Limited
Glytec LLC
Insulet Corporation
LifeScan Inc.
Medtronic plc
Nemaura Medical Inc.
Nightscout Project
Sanofi
Trividia Health Inc.
Verily Life Sciences LLC
CellaVision AB
Horiba Medical
Medica Corporation
Onca Xt Ltd
West Medica
Advanced Cell Diagnostics (ACD)
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc. (ASI)
BioGenex Laboratories, Inc.
BioView Ltd.
Circulomics Inc.
Dako A/S
Definiens
HTG Molecular Diagnostics
Kapa Biosystems Inc.
Leica Biosystems
MilliporeSigma (formerly EMD Millipore)
Omnyx LLC
Visiopharm
BG Medicine, Inc
Binding Site Group Ltd. (The)
Biohit Oyj (Biohit Healthcare)
Biomerica Inc.
Bio-Techne Corporation
Corgenix Medical Corporation
Critical Diagnostics
Eurobio Scientific
EUROIMMUN AG
HOB Biotech
Immunodiagnostic Systems (IDS)
INOVA Diagnostics, Inc.
Integrated Diagnostics (now Biodesix)
One Lambda, Inc
Orgentec Diagnostika
Protagen Diagnostics
Response Biomedical Corp.
Singulex, Inc.
Theradig
VolitionRx Limited
Advaita Corp.
Cerner Corp.
Dell Technologies Inc.
Desktop Genetics Ltd.
DNAnexus Inc.
Edico Genome (Illumina)
Euformatics Oy
Genalice
GenomOncology LLC
Google LLC
Human Longevity Inc.
Intel Corporation
International Business Machines Corp. (IBM)
N-of-One
PierianDx
Rennova Health, Inc.
SOPHiA GENETICS SA
Sunquest Information Systems Inc.
WuXi NextCODE
Accelerate Diagnostics, Inc.
Advanced Biological Laboratories, S.A. (ABL)
altona Diagnostics
ArcDia International Oy Ltd.
BioFire Diagnostics, LLC. (acquired by bioMérieux)
Bruker BioSciences Corporation
COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
Curetis
Fast Track Diagnostics (acquired by Siemens Healthineers)
Focus Diagnostics, Inc.
Genetic Analysis AS
GeneWEAVE Biosciences, Inc.
Greiner Bio-One International GmbH
Hain Lifescience GmbH
Mast Group
Mobidiag Ltd.
Nanosphere, Inc. (Luminex)
OpGen, Inc.
PositiveID Corporation
Q-linea AB
Seegene, Inc.
Synbiosis Ltd.
T2 Biosystems
Asuragen Inc.
AutoGenomics Inc.
Enzo Biochem Inc.
Exosome Diagnostics, Inc.
Fluidigm Corporation
GenMark Diagnostics, Inc
Genome Diagnostics BV (GenDx)
NanoString Technologies, Inc.
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California, Inc. (PacBio)
QuanDx Inc
RainDance Technologies, Inc.
Rubicon Genomics, Inc.
Takara Bio Inc.
Vela Diagnostics
WaferGen Bio-systems, Inc.
Sixteen: Company Profiles: Point of Care Test Specialists
Abaxis, Inc.
Abingdon Health Ltd.
Atlas Genetics Ltd. (Binx Health)
Biomeme, Inc.
Chembio Diagnostic Systems, Inc.
DNA Electronics Ltd (DNAe)
Entopsis
FABPulous B.V.
Fio Corporation
Genedrive plc (formerly Epistem Holdings)
Hema Diagnostic Systems (HDS; dba NuGenerex Diagnostics)
Immunostics, Inc.
InSilixa Inc.
Loop Medical (formerly QloudLab SA)
MedMira, Inc.
OraSure Technologies, Inc.
PTS Diagnostics
QuantuMDx Group, Ltd.
Rheonix, Inc.
Samsung Healthcare
Veredus Laboratories Pte Ltd
Twenty-Eight: Company Profiles: Prenatal Test Service Providers
Affymetrix, Inc.
Berry Genomics Co. ltd.
CombiMatrix (Invitae)
CooperGenomics (Division of CooperSurgical)
Counsyl (Myriad Women’s Health)
GenePeeks, Inc.
Genetadi Biotech S.L.
Genoma Group
Innovations Exchange Pte Ltd (INEX) and iGene Diagnostics Pte Ltd
LifeCodexx AG
Oxford Gene Technology
Premaitha Health (Yourgene Health)
Ravgen
Reproductive Genetics Innovations
Sequenom, Inc.
Twenty-Nine: Company Profiles: Quality Control & Sample Pretreatment Specialists
